Raphelson, Janna R.
Schmickl, Christopher N.
Sonners, Christine
Kreitinger, Kimberly
Grunvald, Eduardo
Horgan, Santiago
Malhotra, Atul
Funding for this research was provided by:
ATS ASPIRE Fellowship
ATS foundation grant
National Institutes of Health (HL134632)
Article History
Received: 10 October 2021
Revised: 13 April 2022
Accepted: 20 April 2022
First Online: 11 May 2022
Declarations
:
: Janna Raphelson has nothing to disclose. Christopher N. Schmickl reports grants from NIH and the ATS Foundation, outside the submitted work. Christine Sonners has nothing to disclose. Kimberly Kreitinger has nothing to disclose. Eduardo Grunvald reports personal fees from Novo Nordisk, personal fees from Gelesis, Inc., and personal fees from Currax Pharmaceuticals, outside the submitted work. Santiago Horgan reports consulting for Stryker, Intuitive, Fortimedix, and Medtronic and presenting for Ethicon. Atul Malhotra is funded by the NIH and reports income related to medical education from LivaNova, Jazz, Equillium, and Corvus outside of the subject matter of this manuscript. ResMed provided a philanthropic donation to affiliated university.